Year: 2026
Type: article
Abstract: INTRODUCTION: Obstructive sleep apnea (OSA) is common among people with obesity (PwO) but remains frequently underrecognized and undertreated. The absence of harmonized screening frameworks in Europe leads to delayed diagnosis, preventable cardiometabolic complications, and increased strain on health systems. This study aimed to establish a Europe-wide expert consensus on the principles, target populations, and practical approaches to OSA screening in adults with obesity, thereby providing a structured framework to guide clinical and policy decisions. METHODS: A two-round, modified mixed-methods Delphi study was conducted in accordance with the ACcurate COnsensus Reporting Document (ACCORD) 2024 reporting guidelines. A total of 20 draft statements across nine domains, informed by a pragmatic literature review, were considered by 26 multidisciplinary experts from European Association for the Study of Obesity (EASO) Collaborating Centres for Obesity Management. An independent Steering Committee oversaw governance and ethics. Consensus was defined as 70% or greater agreement and an interquartile range (IQR) of ≤ 1 on a 5-point Likert scale. RESULTS: All 20 statements met the predefined consensus criteria, particularly those emphasizing prioritization of PwO with cardiometabolic comorbidities, embedding screening within structured care pathways, and timely referral for diagnostic assessment. The STOP-Bang questionnaire was recommended as a first-line tool, with nocturnal oximetry or polysomnography as supplementary options. Consensus-endorsed statements informed a European consensus algorithm detailing who, how, and when to screen. CONCLUSIONS: This expert consensus provides a practical, scalable, and evidence-informed framework for systematic OSA screening within obesity care, supporting harmonized practice, early detection, and multidisciplinary management across European health care.
Source: Advances in Therapy
Institutions: University of Nottingham, Eli Lilly (United Kingdom), Bambino Gesù Children's Hospital, Istituti di Ricovero e Cura a Carattere Scientifico, Istanbul University-Cerrahpaşa, Frederiksberg Hospital, Copenhagen University Hospital, Center for Clinical Research and Prevention, Tel Aviv University, National University Hospital of Iceland
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,790
Funder: Eli Lilly and Company
OpenAlex ID: W7236449579
